Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Use Discussions Should Stay Off-line, FDA Draft Guidance Says

Executive Summary

FDA advises companies to respond to unsolicited requests for off-label information in one-on-one dialogue; the agency also requests public comments on its policies regarding off-label communications in response to an industry citizen petition.

Advertisement

Related Content

Website “Influence” Shouldn’t Make Firms Responsible For Content – PhRMA
FDA Reprint Policy Expands To Clinical Practice Guidelines, Medical Reference Texts
Social Media Guidance Gives Drug Firms A Pass On User Content
Social Media Guidance Gives Drug Firms A Pass On User Content
FDA’s Social Media Guidance Gives Firms A Pass On User-Generated Content
FDA Internet Draft Guidance: Firms Responsible For Promotions On Third-Party Sites
CDER Policy Council Urged To Address Manufacturer/Payer Communications
Social Media Site Could Help FDA Track Adverse Events
FDA Pressed To Clarify Permissible Formulary, Clinical Guideline Communications
Internet-Focused Promotion, Warning Letters Both Up As FDA Guidance Nears

Topics

Advertisement
UsernamePublicRestriction

Register

PS054070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel